Binding of tissue plasminogen activator to endothelial cells - The effect on functional properties. Localization of a ligand in the B-chain of tPA

By Cheng X.-F.   Brohlin M.   Pohl G.   Back O.   Wallen P.  

Thrombosis Research, Vol. 77, Iss. 2, 1995-01 ,pp. : 149-164

Elsevier

Access to resources Recommend Favorite

Antithrombin binding by human umbilical vein endothelial cells: effects of exogenous heparin

By Justus A.C.   Roussev R.   Norcross J.L.   Faulk W.P.  

Thrombosis Research, Vol. 79, Iss. 2, 1995-07 ,pp. : 175-186

Elsevier

Access to resources Recommend Favorite

BINDING OF TISSUE FACTOR PATHWAY INHIBITOR TO CULTURED ENDOTHELIAL CELLS-INFLUENCE OF GLYCOSAMINOGLYCANS - VII: Additional pathway initiating blood coagulation

By Iversen N.   Sandset P.M.   Abildgaard U.   Torjesen P.A.  

Thrombosis Research, Vol. 84, Iss. 4, 1996-11 ,pp. : 267-278

Elsevier

Access to resources Recommend Favorite

The tethered ligand receptor is the responsible receptor for the thrombin induced release of von willebrand factor from endothelial cells (HUVEC)

By Storck J.   Kusters B.   Zimmermann E.R.  

Thrombosis Research, Vol. 77, Iss. 3, 1995-02 ,pp. : 249-258

Elsevier

Access to resources Recommend Favorite

Validation of the human tissue factor/FVIIa complex as an antithrombotic target and the discovery of a synthetic peptide

By Sakariassen Kjell S   Örning Lars  

Future Cardiology, Vol. 3, Iss. 3, 2007-05 ,pp. : 249-262

Future Medicine

Access to resources Recommend Favorite